1
|
Moody CA and Laimins LA: Human
papillomavirus oncoproteins: pathways to transformation. Nat Rev
Cancer. 10:550–560. 2010. View
Article : Google Scholar : PubMed/NCBI
|
2
|
Ferenczy A and Franco E: Persistent human
papillomavirus infection and cervical neoplasia. Lancet Oncol.
3:11–16. 2002. View Article : Google Scholar : PubMed/NCBI
|
3
|
Schiffman M, Castle PE, Jeronimo J,
Rodriguez AC and Wacholder S: Human papillomavirus and cervical
cancer. Lancet. 370:890–907. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Wan F, Miao X, Quraishi I, Kennedy V,
Creek KE and Pirisi L: Gene expression changes during HPV-mediated
carcinogenesis: a comparison between an in vitro cell model and
cervical cancer. Int J Cancer. 123:32–40. 2008. View Article : Google Scholar : PubMed/NCBI
|
5
|
McCoy EL, Iwanaga R, Jedlicka P, et al:
Six1 expands the mouse mammary epithelial stem/progenitor cell pool
and induces mammary tumors that undergo epithelial-mesenchymal
transition. J Clin Invest. 119:2663–2677. 2009. View Article : Google Scholar : PubMed/NCBI
|
6
|
Christensen KL, Brennan JD, Aldridge CS
and Ford HL: Cell cycle regulation of the human Six1 homeoprotein
is mediated by APC(Cdh1). Oncogene. 26:3406–3414. 2007. View Article : Google Scholar : PubMed/NCBI
|
7
|
Micalizzi DS, Wang CA, Farabaugh SM,
Schiemann WP and Ford HL: Homeoprotein Six1 increases TGF-beta type
I receptor and converts TGF-beta signaling from suppressive to
supportive for tumor growth. Cancer Res. 70:10371–10380. 2010.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Ford HL, Kabingu EN, Bump EA, Mutter GL
and Pardee AB: Abrogation of the G2 cell cycle checkpoint
associated with overexpression of HSIX1: a possible mechanism of
breast carcinogenesis. Proc Natl Acad Sci USA. 95:12608–12613.
1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Coletta RD, Christensen K, Reichenberger
KJ, et al: The Six1 homeoprotein stimulates tumorigenesis by
reactivation of cyclin A1. Proc Natl Acad Sci USA. 101:6478–6483.
2004. View Article : Google Scholar : PubMed/NCBI
|
10
|
Cho YS, Kang JW, Cho M, et al: Down
modulation of IL-18 expression by human papillomavirus type 16 E6
oncogene via binding to IL-18. FEBS Lett. 501:139–145. 2001.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Sun C, Li N, Yang Z, et al: miR-9
Regulation of BRCA1 and ovarian cancer sensitivity to cisplatin and
PARP inhibition. J Natl Cancer Inst. 105:1750–1758. 2013.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Xiong T, Zhao Y, Hu D, et al:
Administration of calcitonin promotes blastocyst implantation in
mice by up-regulating integrin beta3 expression in endometrial
epithelial cells. Hum Reprod. 27:3540–3551. 2012. View Article : Google Scholar
|
13
|
Shen Y, Li Y, Ye F, Wang F, Lu W and Xie
X: Identification of suitable reference genes for measurement of
gene expression in human cervical tissues. Anal Biochem.
405:224–229. 2010. View Article : Google Scholar : PubMed/NCBI
|
14
|
Wang W, Fang Y, Sima N, et al: Triggering
of death receptor apoptotic signaling by human papillomavirus 16 E2
protein in cervical cancer cell lines is mediated by interaction
with c-FLIP. Apoptosis. 16:55–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
15
|
Robinson MD, McCarthy DJ and Smyth GK:
edgeR: a Bioconductor package for differential expression analysis
of digital gene expression data. Bioinformatics. 26:139–140. 2010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Anders S, McCarthy DJ, Chen Y, et al:
Count-based differential expression analysis of RNA sequencing data
using R and bioconductor. Nat Protoc. 8:1765–1786. 2013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Draghici S, Khatri P, Bhavsar P, Shah A,
Krawetz SA and Tainsky MA: Onto-Tools, the toolkit of the modern
biologist: Onto-Express, Onto-Compare, Onto-Design and
Onto-Translate. Nucleic Acids Res. 31:3775–3781. 2003. View Article : Google Scholar : PubMed/NCBI
|
18
|
Subramanian A, Tamayo P, Mootha VK, et al:
Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci
USA. 102:15545–15550. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mazurek A, Luo W, Krasnitz A, Hicks J,
Powers RS and Stillman B: DDX5 regulates DNA replication and is
required for cell proliferation in a subset of breast cancer cells.
Cancer Discov. 2:812–825. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Cairns RA and Hill RP: A fluorescent
orthotopic model of metastatic cervical carcinoma. Clin Exp
Metastasis. 21:275–281. 2004. View Article : Google Scholar : PubMed/NCBI
|
21
|
Costa A, Hood IV and Berger JM: Mechanisms
for initiating cellular DNA replication. Annu Rev Biochem.
82:25–54. 2013. View Article : Google Scholar
|
22
|
Soultanas P: Loading mechanisms of ring
helicases at replication origins. Mol Microbiol. 84:6–16. 2012.
View Article : Google Scholar : PubMed/NCBI
|
23
|
Urban M, Joubert N, Purse BW, Hocek M and
Kuchta RD: Mechanisms by which human DNA primase chooses to
polymerize a nucleoside triphosphate. Biochemistry. 49:727–735.
2010. View Article : Google Scholar : PubMed/NCBI
|
24
|
Gan N, Du Y, Zhang W and Zhou J: Increase
of Mcm3 and Mcm4 expression in cervical squamous cell carcinomas.
Eur J Gynaecol Oncol. 31:291–294. 2010.PubMed/NCBI
|
25
|
Cook JG, Park CH, Burke TW, et al:
Analysis of Cdc6 function in the assembly of mammalian
prereplication complexes. Proc Natl Acad Sci USA. 99:1347–1352.
2002. View Article : Google Scholar : PubMed/NCBI
|
26
|
Masuda Y, Suzuki M, Piao J, Gu Y,
Tsurimoto T and Kamiya K: Dynamics of human replication factors in
the elongation phase of DNA replication. Nucleic Acids Res.
35:6904–6916. 2007. View Article : Google Scholar : PubMed/NCBI
|
27
|
Maga G, Stucki M, Spadari S and Hubscher
U: DNA polymerase switching: I. Replication factor C displaces DNA
polymerase alpha prior to PCNA loading. J Mol Biol. 295:791–801.
2000. View Article : Google Scholar : PubMed/NCBI
|
28
|
Lockwood WW, Thu KL, Lin L, et al:
Integrative genomics identified RFC3 as an amplified candidate
oncogene in esophageal adenocarcinoma. Clin Cancer Res.
18:1936–1946. 2012. View Article : Google Scholar : PubMed/NCBI
|
29
|
Arai M, Kondoh N, Imazeki N, et al: The
knockdown of endogenous replication factor C4 decreases the growth
and enhances the chemosensitivity of hepatocellular carcinoma
cells. Liver Int. 29:55–62. 2009. View Article : Google Scholar : PubMed/NCBI
|